163 related articles for article (PubMed ID: 24650028)
1. YKL-40 expression in soft-tissue sarcomas and atypical lipomatous tumors. An immunohistochemical study of 49 tumors.
Harving ML; Christensen LH; Ringsholt M; Lausten GS; Petersen MM
Acta Orthop; 2014 Apr; 85(2):195-200. PubMed ID: 24650028
[TBL] [Abstract][Full Text] [Related]
2. YKL-40 expression could be a poor prognostic marker in the breast cancer tissue.
Kang EJ; Jung H; Woo OH; Park KH; Woo SU; Yang DS; Kim AR; Lee JB; Kim YH; Kim JS; Seo JH
Tumour Biol; 2014 Jan; 35(1):277-86. PubMed ID: 23918300
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
[TBL] [Abstract][Full Text] [Related]
4. Increased tissue immunoexpression of YKL-40 protein in high grade serous ovarian cancers.
Stawerski P; Wągrowska-Danilewicz M; Stasikowska-Kanicka O; Danilewicz M
Pathol Res Pract; 2011 Sep; 207(9):573-6. PubMed ID: 21820815
[TBL] [Abstract][Full Text] [Related]
5. [Expression of TEIF protein in soft tissue tumors and its significance].
Gong YL; Li T; Guo H; Sun Y; Chi YK; Ling Y; Shen Q; Liu HJ; Hou L; Zhang B
Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):651-5. PubMed ID: 17374207
[TBL] [Abstract][Full Text] [Related]
6. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
7. Ki-67 immunoexpression and radiological assessment of necrosis improves accuracy of conventional and modified core biopsy systems in predicting the final grade assigned to adult-soft tissue sarcomas. An international collaborative study.
Machado I; Cruz J; Righi A; Gambarotti M; Ferrari C; Ruengwanichayakun P; Giner F; Rausell N; Lavernia J; Sugita S; Najera L; Suarez L; Sanjuan X; García JAN; García Del Muro FJ; Gómez-Mateo MC; Valladares MM; Ramos-Oliver I; Romagosa C; Parafioriti A; Elisabetta A; di Bernardo A; Navarro S; Hasegawa T; Arana E; Llombart-Bosch A
Pathol Res Pract; 2021 Sep; 225():153562. PubMed ID: 34329836
[TBL] [Abstract][Full Text] [Related]
8. YKL-40 tissue expression and plasma levels in patients with ovarian cancer.
Høgdall EV; Ringsholt M; Høgdall CK; Christensen IJ; Johansen JS; Kjaer SK; Blaakaer J; Ostenfeld-Møller L; Price PA; Christensen LH
BMC Cancer; 2009 Jan; 9():8. PubMed ID: 19134206
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor and soft tissue sarcomas: tumor expression correlates with grade.
Chao C; Al-Saleem T; Brooks JJ; Rogatko A; Kraybill WG; Eisenberg B
Ann Surg Oncol; 2001 Apr; 8(3):260-7. PubMed ID: 11314944
[TBL] [Abstract][Full Text] [Related]
10. YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study.
Senetta R; Duregon E; Sonetto C; Spadi R; Mistrangelo M; Racca P; Chiusa L; Munoz FH; Ricardi U; Arezzo A; Cassenti A; Castellano I; Papotti M; Morino M; Risio M; Cassoni P
PLoS One; 2015; 10(4):e0123759. PubMed ID: 25875173
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of WT1 expression in soft tissue sarcoma.
Kim A; Park EY; Kim K; Lee JH; Shin DH; Kim JY; Park DY; Lee CH; Sol MY; Choi KU; Kim JI; Lee IS
World J Surg Oncol; 2014 Jul; 12():214. PubMed ID: 25026998
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.
Kim C; Kim EK; Jung H; Chon HJ; Han JW; Shin KH; Hu H; Kim KS; Choi YD; Kim S; Lee YH; Suh JS; Ahn JB; Chung HC; Noh SH; Rha SY; Kim SH; Kim HS
BMC Cancer; 2016 Jul; 16():434. PubMed ID: 27393385
[TBL] [Abstract][Full Text] [Related]
13. YKL-40 expression in human hepatocellular carcinoma: a potential biomarker?
Xiao XQ; Hassanein T; Li QF; Liu W; Zheng YH; Chen J
Hepatobiliary Pancreat Dis Int; 2011 Dec; 10(6):605-10. PubMed ID: 22146624
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer.
Kim SH; Das K; Noreen S; Coffman F; Hameed M
World J Surg Oncol; 2007 Feb; 5():17. PubMed ID: 17286869
[TBL] [Abstract][Full Text] [Related]
15. Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma.
Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A
Medicine (Baltimore); 2015 Jul; 94(28):e1142. PubMed ID: 26181552
[TBL] [Abstract][Full Text] [Related]
16. Histological grading and MIB-1 labeling index of soft-tissue sarcomas.
Hasegawa T
Pathol Int; 2007 Mar; 57(3):121-5. PubMed ID: 17295643
[TBL] [Abstract][Full Text] [Related]
17. Federation Nationale des Centers de Lutte Contre le Cancer grading of soft tissue sarcomas on needle core biopsies using surrogate markers.
Lin X; Davion S; Bertsch EC; Omar I; Nayar R; Laskin WB
Hum Pathol; 2016 Oct; 56():147-54. PubMed ID: 27346575
[TBL] [Abstract][Full Text] [Related]
18. Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters.
Hornick JL; Fletcher CD
Am J Surg Pathol; 2003 Sep; 27(9):1183-96. PubMed ID: 12960802
[TBL] [Abstract][Full Text] [Related]
19. High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival.
Roslind A; Johansen JS; Christensen IJ; Kiss K; Balslev E; Nielsen DL; Bentzen J; Price PA; Andersen E
Int J Cancer; 2008 Feb; 122(4):857-63. PubMed ID: 17957792
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of newer prognostic markers for adult soft tissue sarcomas.
Levine EA; Holzmayer T; Bacus S; Mechetner E; Mera R; Bolliger C; Roninson IB; Das Gupta TK
J Clin Oncol; 1997 Oct; 15(10):3249-57. PubMed ID: 9336362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
